BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20938925)

  • 1. Social recognition assay in the rat.
    Mathiasen JR; DiCamillo A
    Curr Protoc Neurosci; 2010 Oct; Chapter 8():Unit 8.5I. PubMed ID: 20938925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel object recognition in the rat: a facile assay for cognitive function.
    Mathiasen JR; DiCamillo A
    Curr Protoc Pharmacol; 2010 Jun; Chapter 5():Unit 5.59. PubMed ID: 22294372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
    de Bruin NM; Prickaerts J; Lange JH; Akkerman S; Andriambeloson E; de Haan M; Wijnen J; van Drimmelen M; Hissink E; Heijink L; Kruse CG
    Neurobiol Learn Mem; 2010 May; 93(4):522-31. PubMed ID: 20132903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of voluntary physical exercise, citicoline, and combined treatment on object recognition memory, neurogenesis, and neuroprotection after traumatic brain injury in rats.
    Jacotte-Simancas A; Costa-Miserachs D; Coll-Andreu M; Torras-Garcia M; Borlongan CV; Portell-Cortés I
    J Neurotrauma; 2015 May; 32(10):739-51. PubMed ID: 25144903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents.
    Gacsályi I; Nagy K; Pallagi K; Lévay G; Hársing LG; Móricz K; Kertész S; Varga P; Haller J; Gigler G; Szénási G; Barkóczy J; Bíró J; Spedding M; Antoni FA
    Neuropharmacology; 2013 Jan; 64():254-63. PubMed ID: 22824189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.
    Barak S; Weiner I
    Pharmacol Biochem Behav; 2011 Aug; 99(2):164-89. PubMed ID: 21420999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute administration of melatonin on attentional, executive, and working memory processes in rats.
    Liet C; Amenouche F; Freret T; Boulouard M; Mauvieux B; Lelong-Boulouard V; Bocca ML
    Fundam Clin Pharmacol; 2015 Oct; 29(5):472-7. PubMed ID: 26194194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist.
    Esbenshade TA; Browman KE; Miller TR; Krueger KM; Komater-Roderwald V; Zhang M; Fox GB; Rueter L; Robb HM; Radek RJ; Drescher KU; Fey TA; Bitner RS; Marsh K; Polakowski JS; Zhao C; Cowart MD; Hancock AA; Sullivan JP; Brioni JD
    J Pharmacol Exp Ther; 2012 Oct; 343(1):233-45. PubMed ID: 22815533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HT1001, a proprietary North American ginseng extract, improves working memory in schizophrenia: a double-blind, placebo-controlled study.
    Chen EY; Hui CL
    Phytother Res; 2012 Aug; 26(8):1166-72. PubMed ID: 22213250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
    Karasawa J; Hashimoto K; Chaki S
    Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical research into cognition enhancers.
    Sarter M
    Trends Pharmacol Sci; 2006 Nov; 27(11):602-8. PubMed ID: 16997388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H₃ receptor antagonists with potent cognition enhancing activity.
    Tao M; Aimone LD; Huang Z; Mathiasen J; Raddatz R; Lyons J; Hudkins RL
    J Med Chem; 2012 Jan; 55(1):414-23. PubMed ID: 22107017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people.
    Ilieva I; Boland J; Farah MJ
    Neuropharmacology; 2013 Jan; 64():496-505. PubMed ID: 22884611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aged rhesus monkeys: Cognitive performance categorizations and preclinical drug testing.
    Plagenhoef MR; Callahan PM; Beck WD; Blake DT; Terry AV
    Neuropharmacology; 2021 Apr; 187():108489. PubMed ID: 33561449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus.
    Tarragon E; Lopez D; Estrada C; Gonzalez-Cuello A; Ros CM; Lamberty Y; Pifferi F; Cella M; Canovi M; Guiso G; Gobbi M; Fernández-Villalba E; Blin O; Bordet R; Richardson JC; Herrero MT
    Neuropharmacology; 2014 Oct; 85():206-14. PubMed ID: 24878242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-amnesic properties of (+/-)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats.
    Antonini V; Prezzavento O; Coradazzi M; Marrazzo A; Ronsisvalle S; Arena E; Leanza G
    J Neurochem; 2009 May; 109(3):744-54. PubMed ID: 19245662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptors.
    Castner SA; Smagin GN; Piser TM; Wang Y; Smith JS; Christian EP; Mrzljak L; Williams GV
    Biol Psychiatry; 2011 Jan; 69(1):12-8. PubMed ID: 20965497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycinamide prevents MK-801-induced hyperactivity and deficits in object recognition memory in an animal model of positive and cognitive symptoms of schizophrenia.
    Basurto E; Flores OG; Hoffman KL
    Schizophr Res; 2015 Aug; 166(1-3):349-50. PubMed ID: 25823398
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic effects of ceftriaxone and erythropoietin on neuronal and behavioral deficits in an MPTP-induced animal model of Parkinson's disease dementia.
    Huang CK; Chang YT; Amstislavskaya TG; Tikhonova MA; Lin CL; Hung CS; Lai TJ; Ho YJ
    Behav Brain Res; 2015 Nov; 294():198-207. PubMed ID: 26296668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.